Biotech Stock news from FierceBiotech
News
CRO stocks boom despite market problems
The rest of Wall Street (except biotech) may be suffering, but according to the Motley Fool, CRO stock is hot. Big Pharma and small Read more...
In tough market, biotech shines
Wall Street has been in a tough spot these last few months, with the S&P 500 losing 9.5 percent over the course of June and July. But the biotech industry has Read more...
Discovery secures $60M financing deal
Struggling Discovery Labs signed a three year, $60 million financing deal with Kingsbridge Capital, a U.K.-based investment group. Kingsbridge will provide the capital through the purchase of newly Read more...
Somaxon secures cash for Silenor marketing
As Somaxon waits for the FDA okay on insomnia treatment Silenor, the company has lined up funding for marketing and commercialization of the drug. The company inked a $15 million secured loan Read more...
ASCO braces for massive data dump before meeting
The analysts devoted to tracking biotech companies in the oncology arena will have their hands full tomorrow night at 9 p.m. EST. That's when ASCO will do an online data dump in advance of its annual Read more...
Big Biotech emerges as a shelter in economic storm
Veteran investors have long taken different views of biotechnology, sometimes in the course of a single day. And share prices regularly go on a Read more...
Vivus land $30M for Phase III work
Vivus has garnered a $30 million funding collaboration with Deerfield Management to advance work on the company's ED drug avanafil. Using $20 million from a Royalty and Funding Agreement and $10 Read more...
Amgen - Big Biotech's Stock Report
Company: Amgen Starting stock price: $70.37 Ending stock price: $46.44 Percent Change: 34% Scoop: The world's biggest biotech suffered its toughest year to date in 2007. Read more...
Genentech - Big Biotech's Stock Report
Company: Genentech Starting stock price: $81.80 Ending stock price: $67.07 Percent Change: -18% Scoop: Genentech's stock slowly declined in ’07 as investors realized that the company's amazing Read more...
Genzyme - Big Biotech's Stock Report
Company: Genzyme Starting stock price: $65.73 Ending stock price: $74.97 Percent Change: 12.97% Scoop: When Biogen Idec put itself up for sale, many wondered whether Genzyme would do the same, Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets